Moreover, plasma sVCAM1 level was positively correlated with the levels of plasma p-Tau181 (tau phosphorylated at threonine-181) and plasma NfL (neurofilament light polypeptide), which are AD biomarkers that can indicate disease stage (Fig. 6b,d). Here, MAPT is linked to Alzheimer disease.